Effectiveness of antiarrhythmic drugs for shockable cardiac arrest: A systematic review.

@article{Ali2018EffectivenessOA,
  title={Effectiveness of antiarrhythmic drugs for shockable cardiac arrest: A systematic review.},
  author={Muhammad Usman Ali and Donna Fitzpatrick-Lewis and Meghan Kenny and Parminder Raina and Dianne L. Atkins and Jasmeet Soar and Jerry P. Nolan and Giuseppe Ristagno and Diana Sherifali},
  journal={Resuscitation},
  year={2018},
  volume={132},
  pages={
          63-72
        }
}
PURPOSE The purpose of this systematic review is to provide up-to-date evidence on effectiveness of antiarrhythmic drugs for shockable cardiac arrest to help inform the 2018 International Liaison Committee on Resuscitation Consensus on Science with Treatment Recommendations. METHODS A search was conducted in electronic databases Medline, Embase, and Cochrane Library from inception to August 15, 2017. RESULTS Of the 9371 citations reviewed, a total of 14 RCTs and 17 observational studies met… 
Lidocaine versus Amiodarone for Pediatric In-Hospital Cardiac Arrest: An Observational Study.
TLDR
In children with cardiac arrest receiving antiarrhythmics for a shockable rhythm, there was no significant difference in clinical outcomes between those receiving lidocaine compared to amiodarone.
Translation from animal studies of novel pharmacological therapies to clinical trials in cardiac arrest: A systematic review.
BACKGROUND There is a lack of new promising therapies to improve the dismal outcomes from cardiac arrest. The objectives of this study were: (1) To identify novel pharmacological therapies
European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest.
TLDR
This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.
Inhaled xenon neuro- and cardioprotection following out-of-hospital cardiac arrest. A randomized, controlled trial
TLDR
Combining inhaled xenon and therapeutic hypothermia in cardiac arrest patients was safe and feasible and significantly attenuated brain white matter injury illustrated with higher FA-values, translating to significant neuroand cardioprotection against ongoing ischaemia-reperfusion injury by xenon inhalation combined with hypotheria.
2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
TLDR
This summary addresses the role of antiarrhythmic drugs in adults and children and includes the Advanced Life Support Task Force and Pediatric Task Force consensus statements, which summarize the most recent published evidence and an assessment of the quality of the evidence based on Grading of Recommendations, Assessment, Development, and Evaluation criteria.
2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
TLDR
This summary addresses the role of antiarrhythmic drugs in adults and children and includes the Advanced Life Support Task Force and Pediatric Task Force consensus statements, which summarize the most recent published evidence and an assessment of the quality of the evidence based on Grading of Recommendations, Assessment, Development, and Evaluation criteria.
Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations☆
This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations for advanced life support includes updates on multiple
Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations for advanced life support includes updates on multiple
Updates in Cardiac Arrest Resuscitation.
TLDR
Current treatment recommendations for adult nontraumatic cardiac arrest are focused on, with emphasis on the latest evidence and controversies regarding intracardiac arrest management.
Antiarrhythmics in patients with out-of-hospital-cardiac arrest do not improve survival to hospital discharge
TLDR
This data indicates that admissions to Kings County Hospital Center and Jackson South Medical Center are likely to be high-risk areas for future research, and the use of these sites as referral sites for further studies is recommended.
...
1
2
3
...

References

SHOWING 1-10 OF 61 REFERENCES
Amiodarone or lidocaine for cardiac arrest: A systematic review and meta-analysis.
TLDR
A systematic review and meta-analysis of randomized clinical trials according to resuscitation with amiodarone vs lidocaine vs placebo found that neither amioarone nor lidocane improve long-term outcome.
Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review
  • M. McBride, B. Marino, +4 authors D. Atkins
  • Medicine
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  • 2017
TLDR
The confidence in effect estimates is so low that the International Liaison Committee on Resuscitation felt that a recommendation to use of amiodarone over lidocaine is too speculative; it is suggested that amioarone or lidocane can be used in the setting of pulseless ventricular tachycardia/ventricular fibrillation in infants and children.
Anti-arrhythmics in out-of-hospital cardiac arrest: lessons from a randomized controlled trial.
TLDR
The study suggests that the survival could be improved by amiodarone administration versus placebo, in the particular case of bystander witnessed OHCA.
Magnesium in cardiac arrest (the magic trial).
TLDR
The use of high dose magnesium as first line drug therapy for OHCA was not associated with a significantly improved survival and early defibrillation remains the single most important treatment for ventricular fibrillation (VF).
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
  • J. Patel
  • Medicine
    The New England journal of medicine
  • 2016
TLDR
The authors reply: A substudy is under way to examine whether the trial might yield observations regarding risk factors for the development of postoperative atrial fibrillation, which would be useful in defining candidates for preventive therapy.
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
TLDR
Overall, neither amiodarone nor lidocaine resulted in a significantly higher rate of survival or favorable neurologic outcome than the rate with placebo among patients with out-of-hospital cardiac arrest due to initial shock-refractory ventricular fibrillation or pulseless ventricular tachycardia.
Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest.
TLDR
The results suggest that procainamide, as administered in this investigation, does not have a large impact on outcome, but cannot eliminate the possibility of a smaller, clinically relevant effect on survival.
The use of amiodarone for in-hospital cardiac arrest at two tertiary care centres.
TLDR
Use of intravenous amiodarone for resuscitation in the institutions, use was less than 50% and no clinically observable survival benefit could be documented, and these results should provoke other institutions to question whether amioarone has improved survival of cardiac arrest under the conditions prevailing in their hospitals.
Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias*
TLDR
The hypothesis that inpatients with cardiac arrest may have different benefits from lidocaine and amiodarone than previously demonstrated is generated and Prospective studies evaluating these agents are warranted.
A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation
TLDR
Intravenous magnesium given early in patients suffering CA with refractory or recurrent VF did not significantly improve the proportion with a ROSC or who were discharged from hospital alive.
...
1
2
3
4
5
...